Report Categories
View AllRecent Articles
View All
Nike Stock Rebound Prospects Remain Uncertain Amid Ongoing Challenges
JM Smucker Faces Analyst Adjustments as JPMorgan Lowers Price Target
Chicago Area Inflation Data Released for April 2026
Retail Hiring Surge Masks Consumer Caution April Jobs Data Sparks Concerns
Chinese AI Startup DeepSeek Claims CostEffective Model Training Without CuttingEdge Chips
SOBR Q3 2025 Earnings Negative EPS Reported No Revenue Disclosed
Neonode Q1 2026 Earnings EPS Misses Estimates Amid Limited Revenue Disclosure
CPHI Q3 2011 Earnings EPS Falls Short of Consensus Amid Operational Headwinds
AGNC Q1 2026 Earnings EPS Surges Past Estimates as Stock Gains Ground
Regis Corporation RGS Q1 2026 Earnings Positive EPS of 060 Signals Operational Improvement
Tucows Inc TCX Holds Steady Near Support as Trading Volume Remains Subdued
Foxx Development Holdings Inc FOXX Slides 2 as Shares Test Key Support Near 367
Toro Corp TORO Falls 185 Nears Critical Support at 504
Toast Inc TOST Surges 474 Key Levels and Potential Scenarios
Momentus Stock Jumps 26 After Announcing 25 Million Private Placement
Artisan Value Fund Highlights Amazoncoms Durable Competitive Advantages
EUs Industrial Dependence on China Raises Concerns Across Five Key Sectors
Visa Warns AI Is Supercharging Scams What Once Required Deep Technical Skill Can Now Be Executed with a Prompt
External Links
Workday Shares Surge 5 on Improved Margin Outlook Amid AIDriven Growth
MH Q1 2026 Earnings EPS Surges 18455 Above Estimates Stock Retreats on Uncertain Outlook
AEMD Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares Modestly
BFLY Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Uptick
HSTM Q1 2026 Earnings EPS Surpasses Estimates by Over 21
Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies
NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline
Uxin Q1 2025 Earnings Widening Losses and Stock Decline Highlight Persistent Challenges
LW Q1 2026 Earnings EPS Beats Estimates by 14 Shares Slide Despite Strong Profit Performance
Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development